您的购物车当前为空
别名 hzVSF-v13
Burfiralimab (hzVSF-v13) 是一种针对波形蛋白的单克隆免疫球蛋白(IgG4),具有抗HBV作用,可用于研究类风湿关节炎。

为众多的药物研发团队赋能,
让新药发现更简单!
Burfiralimab (hzVSF-v13) 是一种针对波形蛋白的单克隆免疫球蛋白(IgG4),具有抗HBV作用,可用于研究类风湿关节炎。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,990 | In stock | |
| 5 mg | ¥ 4,970 | In stock | |
| 10 mg | ¥ 6,880 | In stock | |
| 25 mg | ¥ 9,870 | In stock | |
| 50 mg | ¥ 13,700 | In stock | |
| 100 mg | ¥ 18,500 | In stock |
Burfiralimab 相关产品
| 产品描述 | Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) directed against waveform proteins that has anti-HBV effects and can be used to study rheumatoid arthritis, |
| 别名 | hzVSF-v13 |
| CAS No. | 2460809-80-5 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容